Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

Clinical trial NCT03728972 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03728972
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NK/T-Cell Lymphoma of Nasal Cavity (Diagnosis)NK/T-Cell Lymphoma of Nasopharynx (Diagnosis)

Start date: 2018-11-09
Primary completion: 2025-06-15
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.